Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY antimicrobial surveillance program 1997-1998

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 20, Issue 9, 2001, Pages 617-625

  Fluit, A ^a   Verhoef, J ^a   Schmitz, F ^a   Sentry Participants, The European ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CARBAPENEM DERIVATIVE; CEFEPIME; LINEZOLID; MEROPENEM; MINOCYCLINE; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EUROPE; HAEMOPHILUS INFLUENZAE; HOSPITAL; INTENSIVE CARE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0034786798     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960100564     Document Type: Article

References (26)

1. High risk of hospital-acquired infection in the ICU patient
2. Hospital acquired infections in intensive care unit patients: An overview with emphasis on epidemics
3. Septicemia in 980 patients at a university hospital in Berlin: Prospective studies during 4 selected years between 1979 and 1989
4. Major trends in the microbial etiology of nosocomial infection
5. Preventing nosocomial pneumonia: State of the art and perspectives for the 1990s
6. A 25-year study of nosocomial bacteremia in an adult intensive care unit
7. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study
8. Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study)
9. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries
10. A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey
11. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program
12. External sources of vancomycin-resistant enterococci for intensive care units
13. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control
14. Surveillance of antibiotic resistance in ICUs in southeastern
15. Bacterial pathogens isolated from patients with bloodstream infections: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
16. Drug resistance in intensive care units
17. Empiric therapy of sepsis in the surgical intensive care unit with broad-spectrum antibiotics for 72 hours does not lead to the emergence of resistant bacteria
18. Treating patients with severe sepsis
19. Predominant pathogens found in the European prevalence of infection in intensive care study
20. A multicentre survey of antimicrobial resistance in gram-negative isolates from Belgian intensive care units in 1994-1995
21. Epidemiology of infection in ICUs
22. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an international surveillance programme
23. Antimicrobial resistance among community-acquired pneumonia isolates in Europe: First results from the SENTRY antimicrobial surveillance program 1997
24. Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: Results from the SENTRY antimicrobial surveillance program 1997
25. Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs: A 1997 surveillance trial in 102 medical centers in the United States